By Business & Finance 
Since its foundation in 2005, Diaceutics has stood as a trailblazer in precision medicines. The company is one of the finalists for the coveted Elevation Award, in association with Enterprise Ireland.
Reach
Over the last 12-24 months, Diaceutics has significantly expanded its reach. At the heart of this success lies its DxRX platform—the world’s first diagnostic network for precision medicine.
This digital infrastructure seamlessly connects laboratories, pharmaceutical companies, and clinicians, ensuring efficient patient testing, promoting faster drug development, and streamlining launches.
Diaceutics has witnessed a notable growth in market share. The company’s data-driven approach, capitalising on its vast patient testing database, has optimised drug prescription practices for pharmaceutical brands, boosting turnover.
International
Internationally, Diaceutics has broadened its footprint across key global markets, ensuring that the insights and benefits of precision medicine are accessible across boundaries.
The company’s efforts have resonated in various regions, further solidifying its position as a leader in the space of precision medicines.
ESG
Diaceutics demonstrates unwavering commitment to Environmental, Social, and Governance (ESG) goals.
Governance: The company upholds a transparent and responsible approach to operations, with a governance structure ensuring accountability at all levels. Regular audits maintain integrity, and leadership fosters a culture of openness and responsibility.
CSR (Corporate Social Responsibility): Diaceutics’ dedication to precision medicine inherently serves a larger social cause—ensuring patients access the right therapies. Actively engaging in partnerships and initiatives, the company prioritises community well-being and healthcare accessibility.
Environmental Strategies: Diaceutics aims to minimise its carbon footprint. Sustainable practices, from energy-efficient infrastructure to digital solutions reducing the need for physical logistics, showcase a commitment to a greener operational model.
Business & Finance Awards Elevation Award
The Elevation Award category was launched in 2018, in partnership with Enterprise Ireland. This award recognises Irish companies that are fast-growing and with significant potential to continue to scale globally. The Award complements the well-established Company of the Year Award.
Previous winners of the prestigious prize include Portwest in 2018, Wisetek in 2019, Aerogen in 2020, APC ltd. in 2021, and FINEOS in 2022.
Attend the Awards
The award ceremony holds an important date for Irish and international business and political leaders as we recognise those paving the way for business excellence on the island of Ireland and beyond. Given demand, table availability is limited – for further information Contact Zoe.Metro@businessandfinance.com – for Partnership opportunities contact brian.kearns@businessandfinance.com.
For more information on the 49th annual Business & Finance Awards see www.businessandfinanceawards.com
MEET OUR ELEVATION AWARD FINALISTS:
LearnUpon, transforming how organisations deliver, track and report on training
Mail Metrics, transforming paper-based businesses to fully digital end-to-end processes
CWSI, security solutions for remote and hybrid working
Fenergo Limited, future-proofing client lifecycle management
Siren, transforming investigations for law enforcement and national security globally
XOCEAN, a leading provider of carbon-neutral ocean data
GridBeyond, future-proofing energy systems of tomorrow
Integrity360, trusted security advisor for over 3,000 clients
